drugset
drugset / Trial / NCT00039351

Combination Chemotherapy in Treating Older Patients With Non-Hodgkin's Lymphoma

NCT00039351 ↗

Phase 2 Completed 32 enrolled European Organisation for Research and Treatment of Cancer - EORTC
Open-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating older patients who have non-Hodgkin's lymphoma.

Timeline

Start
2002-03
Primary completion
2005-01
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclophosphamide Other / unclassified — Intravenous
Subject Prednisone Other / unclassified — Oral
Subject Vincristine Small molecule — Intravenous

Indications

lymphoma